Radient Pharmaceuticals Corporation is a dynamic brand operating in the healthcare sector. With a focus on innovation, Radient offers a range of cutting-edge products and services aimed at improving patient outcomes. The company's stock, listed under the symbol RXPCD on the OTCQX exchange, currently trades at $0.

038. Stay updated on the latest stock information, including any changes, with a detailed stock quote available on their website. At Radient Pharmaceuticals, their commitment to shareholders is evident through transparent communication and regular updates.

Access shareholder meeting information, annual reports such as the 2010 10K and 2011 Q2-10Q, as well as proxy statements. Explore the diverse product portfolio and partnerships that drive Radient's success in the healthcare industry. Stay informed through their investor channels and video presentations.

Be in the know with the latest news and announcements, such as their 2012 Sales, Advertising & Outreach Plan presentation, abstracts presented at the Gastrointestinal Cancer Symposium, and more. Experience the innovation and dedication of Radient Pharmaceuticals Corporation